allogeneic car-nk cell therapy in r/r aml/mds
Published 3 years ago • 441 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
2:53
safety and efficacy of allogeneic car-t cell treatment
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
1:12
novel all treatment strategies: car t-cells
-
3:10
universal car-t therapy for t-all
-
3:33
an overview of the car t-cell therapy story
-
1:26
the safety and efficacy of allosct following car-t cell therapy for large b-cell lymphoma
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
21:38
drawing the line: the rationale behind blood tube collection order
-
11:18
car-t cells: engineered cancer killers
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
2:56
the prognostic significance of mgus-like profiles in transplant-eligible patients with myeloma
-
4:10
car t-cell therapy for all
-
2:46
allo-715: novel allogenic car t-cell therapy in myeloma
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
8:16
future avenues for car t-cell therapy in all
-
0:51
developing universal car-t therapies for t-all
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
1:08
advantages and current status of off-the-shelf car-ts
-
9:48
iwal 2019: car-t & cellular therapies in aml and all
-
1:48
do all patients require maintenance therapy following allosct?